SK hynix to Invest 54 Trillion Won, Weighs Sale of China Chongqing Plant
SK hynix said its board approved total investment of about 54.3 trillion won to build DRAM fab “Y2” in Yongin (35.2 trillion won) and NAND fab “M17” in Cheongju (19.1 trillion won), targeting next-generation DRAM/HBM and NAND capacity. It is also reportedly reviewing options to sell its stake in a Chongqing packaging plant, with enterprise value forecast near $3 billion, per Bloomberg.
How this was made
The 30-second read
Why it matters
Board-approved capex increases capacity visibility for next-generation DRAM/HBM (Yongin Y2) and NAND (Cheongju M17). Separately, early-stage discussions on selling a Chongqing packaging stake introduce a potential capital-recycling and China-risk variable, but deal certainty is low.
Market read
Traders can update expectations for AI-memory supply buildout in Korea and monitor deal headlines around the Chongqing stake sale for potential capital and risk re-pricing.
What to watch
HBM competition and pricing are not addressed; the market may focus on demand durability and margin impact rather than capacity additions, plus any sale terms and regulatory friction in China are unspecified.
Background
SK hynix is expanding domestic DRAM and NAND capacity to meet AI-driven memory demand, while reviewing a China packaging-plant stake sale.
Ticker impact
SK hynix approved 35.2 trillion won for the Yongin Y2 DRAM/HBM fab and 19.1 trillion won for the Cheongju M17 NAND fab.
Likely positive bias for SK hynix shares on capex visibility, with volatility around any China Chongqing stake-sale outcome.
The article provides concrete board-approved investment amounts, timelines for cleanroom openings, and a potential China asset sale with an estimated enterprise value, all of which can reprice growth and risk assumptions.
Market effects
Reinforces the AI-memory capex cycle (HBM/DRAM and enterprise SSD/NAND) and may intensify competitive pressure on Samsung’s HBM roadmap.
Supports Korea-based semiconductor manufacturing footprint, potentially affecting regional supply-chain and equipment demand expectations.
China footprint realignment risk could influence cross-border packaging capacity and regional memory supply logistics.
Counterpoint
Large capex and long cleanroom ramp (2028-2029+) may not translate into near-term earnings upside, and the China stake sale could be delayed or fail.
Key entities
- companySK hynix
Board approved 35.2 trillion won (Yongin Y2 DRAM/HBM) and 19.1 trillion won (Cheongju M17 NAND), and is reviewing a Chongqing packaging stake sale.
- projectYongin Y2
Next-generation DRAM/HBM fab, construction begins July next year, first cleanroom June 2029, staged through Oct 2031.
- projectCheongju M17
New NAND fab, construction begins Feb next year, first cleanroom Dec 2028, investment through Apr 2031.
- assetChongqing packaging plant stake
SK hynix reportedly reviewing sale options; potential enterprise value around $3 billion (about 4 trillion won) if a deal occurs.
